Monitoring medical gas xenon concentration using ultrasonic gas analyser
    1.
    发明申请
    Monitoring medical gas xenon concentration using ultrasonic gas analyser 失效
    使用超声波气体分析仪监测医用气体氙浓度

    公开(公告)号:US20060021421A1

    公开(公告)日:2006-02-02

    申请号:US10512797

    申请日:2003-05-01

    Abstract: The concentration of xenon, in a medical gas mixture of xenon as an active component with a known composition of oxygen and, optionally, nitrogen and/or helium recirculating through a medical device (103) in which carbon dioxide is introduced into the mixture, is monitored by removal (135, 133) of carbon dioxide downstream of the medical device (103) and subsequently passing the carbon dioxide-free gas through an ultrasonic gas analyser (143) upstream of the medical device. The gas analyzer determines the xenon concentration by measuring the time delay between transmission of an ultrahigh frequency ultrasonic pulse of at least 100 kHz axially through the sample chamber from a location at one end thereof and reflection of said pulse axially from the other end of the sample chamber back to said location. An analyser of novel construction is disclosed.

    Abstract translation: 氙作为具有已知组成的氧的活性成分的医用气体混合物的浓度,以及任选地通过将二氧化碳引入混合物的医疗装置(103)再循环的氮和/或氦的混合物为 通过在医疗装置(103)的下游去除(135,133)二氧化碳并随后使无二氧化碳气体通过医疗装置上游的超声波气体分析器(143)来监测。 气体分析仪通过测量从其一端的位置轴向通过样品室的至少100kHz的超高频超声脉冲的透射之间的时间延迟以及从样品的另一端轴向反射所述脉冲的时间延迟来确定氙浓度 房间回到所述位置。 公开了一种新颖的结构分析仪。

    Radiation-curable release compositions, use thereof and release coated substrates
    2.
    发明授权
    Radiation-curable release compositions, use thereof and release coated substrates 有权
    可辐射固化的剥离组合物,其用途和脱模涂层的基材

    公开(公告)号:US06548568B1

    公开(公告)日:2003-04-15

    申请号:US09546791

    申请日:2000-04-11

    Abstract: A radiation-curable release composition comprises: (a) from about 50 to about 100 parts by weight of an organopolysiloxane of the formula (I)  wherein R is CH2═CH—C(O)—O—CH2—CH(OH)—CH2—O—CH2—CH2—CH2—, n is 5 to 15, and p is 50 to 150; (b) from 0 to about 50 parts by weight of one or more organopolysiloxanes comprising organopolysiloxanes selected from the group consisting of those of formulae (II) and (III)  wherein R is CH2═CH—C(O)—O—CH2—CH(OH)—CH2—O—CH2—CH2—CH2—, m is 1 to 10, and q is 151 to 300; and  wherein R is CH2═CH—C(O)—O—CH2—CH(OH)—CH2—O—CH2—CH2—CH2—, and r is 20 to 500; (c) from 0 to about 10 parts by weight of an organopolysiloxane of formula (IV)  wherein R is CH2═CH—C(O)—O—CH2—CH(OH)—CH2—O—CH2—CH2—CH2—, s is 1 to 10, and t is 301 to 1000; (d) from 0 to about 10 parts by weight of at least one additive for modifying the adhesion and flexibility properties of the composition, the at least one additive selected from the group consisting of acrylate and vinyl ether monomers; and (e) from 0 to about 10 parts by weight of a photoinitiator. For easier release, at least one of component (b) or (c) is preferably present in the composition.

    Abstract translation: 可辐射固化的释放组合物包含:(a)约50至约100重量份的式(I)的有机聚硅氧烷,其中R是CH 2 = CH-C(O)-O-CH 2 -CH(OH) - CH 2 -O-CH 2 -CH 2 -CH 2 - ,n为5至15,p为50至150;(b)0至约50重量份的一种或多种有机聚硅氧烷,其包含选自以下的有机聚硅氧烷: 式(II)和(III)其中R为CH 2 = CH-C(O)-O-CH 2 -CH(OH)-CH 2 -O-CH 2 -CH 2 -CH 2 - ,m为1至10,q为151 至300; 并且其中R为CH 2 = CH-C(O)-O-CH 2 -CH(OH)-CH 2 -O-CH 2 -CH 2 -CH 2 - ,r为20至500;(c)0至约10份 其中R为CH 2 = CH-C(O)-O-CH 2 -CH(OH)-CH 2 -O-CH 2 -CH 2 -CH 2 - 的式(Ⅳ)的有机聚硅氧烷的重量为1〜10,t为 301至1000;(d)0至约10重量份的至少一种用于改变组合物的粘合性和柔软性的添加剂,所述至少一种选自丙烯酸酯和乙烯基醚单体的添加剂; 和(e)0至约10重量份的光引发剂。为了更容易的释放,组合物中优选存在组分(b)或(c)中的至少一种。

    Medical gas recirculation system
    3.
    发明申请
    Medical gas recirculation system 审中-公开
    医用气体循环系统

    公开(公告)号:US20060231098A1

    公开(公告)日:2006-10-19

    申请号:US10512740

    申请日:2003-05-01

    Abstract: A medical device (103) is supplied (105) with a gas mixture from a higher pressure section of a main circuit (102) in which medical gas recirculates though the higher pressure section and a lower pressure section. Decontaminated spent gas is returned to the lower pressure section of the main circuit Pressure in the higher pressure section is maintained by a pressure maintaining valve (141) and gas flow in the main circuit is maintained by a volume regulator (145) in the lower pressure section. The composition of the recirculating gas mixture is maintained by addition of respective feed gases in response to concentration and/or volume variation measurement. The method has particular application to the feed of a binary oxygen/xenon mixture to a cardiopulmonary bypass oxygenator or an artificial ventilator.

    Abstract translation: 提供医疗装置(105),其具有来自主回路(102)的高压部分的气体混合物,其中医疗气体通过较高压力部分和较低压力部分再循环。 净化的废气返回到主回路的低压部分通过保压阀(141)维持高压部分的压力,主回路中的气体流量由较低压力的体积调节器(145)保持 部分。 循环气体混合物的组成通过响应于浓度和/或体积变化测量而添加相应的进料气体来维持。 该方法特别适用于将二氧化氙混合物进料至心肺旁路氧合器或人造呼吸机。

    Initiators for the cationic crosslinking of polymers containing
organofunctional groups
    5.
    发明授权
    Initiators for the cationic crosslinking of polymers containing organofunctional groups 失效
    用于阳离子交联含有有机官能团的聚合物的引发剂

    公开(公告)号:US5703137A

    公开(公告)日:1997-12-30

    申请号:US616170

    申请日:1996-03-14

    Abstract: The present invention relates to initiators for the polymerization and/or crosslinking, cationically and under photochemical and/or thermal activation and/or activation by a beam of electrons, of monomers and/or polymers containing organofunctional groups. The said initiators are of the type comprising an onium salt of an element from groups 15 to 17 of the Periodic Table (Chem & Eng News, Vol 63, N5, 26, of 4 Feb. 1985) and they are characterized in that they contain at least one polymerization and/or crosslinking accelerator chosen from .alpha.-hydroxylated carboxylic acid esters such as, for example, lactic acid esters. Another subject of the invention is compositions based on at least one cationically crosslinkable polyorganosiloxane and on at least one initiator.

    Abstract translation: 本发明涉及用于聚合和/或交联的阳离子和光活化和/或热活化和/或通过电子束,含有有机官能团的单体和/或聚合物进行激活的引发剂。 所述引发剂的类型包括元素周期表第15-17族元素的鎓盐(Chem&Eng News,Vol 63,N5,26,1985年2月4日),它们的特征在于它们含有 选自α-羟基化羧酸酯的至少一种聚合和/或交联促进剂,例如乳酸酯。 本发明的另一主题是基于至少一种阳离子交联聚有机硅氧烷和至少一种引发剂的组合物。

Patent Agency Ranking